Blackrock Floating Rate Income Strategies Fund Inc (FRA)
Live price chart, market sentiment, and community perspectives for Blackrock Floating Rate Income Strategies Fund Inc (NYSE: FRA).
Live price chart, market sentiment, and community perspectives for Blackrock Floating Rate Income Strategies Fund Inc (NYSE: FRA).
On our desk, we are closely tracking FRA's current share price of $10.85 against its NAV of $11.38, which reflects a 4.66% discount. Given that the 52-week average discount sat tighter at -1.28%, this widening presents an interesting entry window for income-focused accounts. However, market sentiment cautions that closed-end fund discounts can persist or expand if broader credit spreads widen. We advise clients to weigh the attractive 13.69% managed distribution rate against the underlying leverage and liquidity profile before establishing oversized positions.
Reviewing the portfolio's fixed-income breakdown, the heavy concentration in U.S. senior loans and ETFs—such as the Invesco Senior Loan ETF and SPDR Blackstone/GSO Senior Loan—gives FRA a distinct floating-rate advantage in a higher-for-longer yield environment. Nevertheless, looking at the maturity and credit quality data, one must account for the systemic credit risks embedded in leveraged loan portfolios. If corporate defaults tick up, underlying holdings like Alliant Holdings, TransDigm, and Allied Universal could face pressure, directly impacting net asset value stability.
When analyzing fixed-income closed-end funds like FRA for quantitative modeling, candidates should immediately look past the headline double-digit yield and inspect the balance sheet mechanics—specifically the short-term borrowing components like the overnight facility shown in the top holdings. Leverage amplifies both income generation and capital drawdown risk. Make sure your evaluation incorporates the fund's beta of 0.4 relative to historical monthly metrics, treating it as a specialized portfolio diversifier rather than a core capital appreciation vehicle.
Explore plasma cleansing, somatic organ swaps, and BCI.